ISSN:

Journal Home

ImmunoTargets and Therapy Q1 Unclaimed

Dove Medical Press Ltd. New Zealand

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

ImmunoTargets and Therapy is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 25. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1602 €. The scope of the journal is focused on immunology, immune system, immune-based therapy. It has an SJR impact factor of 2,14 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,14.

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Immunology (Q1) Immunology and Allergy (Q1) Immunology and Allergy (Q1)

Price

1602 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

2,14

SJR Impact factor

25

H Index

14

Total Docs (Last Year)

63

Total Docs (3 years)

768

Total Refs

498

Total Cites (3 years)

62

Citable Docs (3 years)

6.56

Cites/Doc (2 years)

54.86

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Reviews Microbiology Q1
Science immunology Q1
Nature Microbiology Q1
Cell Host and Microbe Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Immunology Immune system Immune-based therapy